Our patented atraumatic method offers a gentler and more effective approach to hormone pellet therapy, prioritizing patient comfort, minimizing tissue damage, and optimizing hormone delivery.
Our innovative atraumatic method offers a superior approach to traditional hormone pellet therapy, prioritizing patient comfort and optimizing treatment outcomes. By using a specialized blunt-tipped trocar, we minimize tissue damage and ensure secure pellet placement. This enhances hormone delivery by avoiding hematoma formation, a blood barrier that can hinder hormone absorption. A consistent release of our bioidentical testosterone or estrogen promotes long-lasting symptom relief and improves your overall well-being.
We’ve found that over 85 percent of patients report a positive experience and are likely to return for future treatments, resulting from benefits, including:
Traditional sharp-tip trocars can create a hematoma, which can delay hormone absorption and increase the risk of pellet extrusion. The absorption process with this traditional method can take three to five weeks, and patient downtime significantly varies. Because of a poor patient experience and complicated process, less than 50 percent of patients return for future treatments.
Virden Method™ uses our blunt-tipped atraumatic trocars, minimizing tissue damage and preventing the formation of hematomas. This allows for immediate hormone absorption and a faster recovery time, elevating the patient experience. We’ve seen over 85 percent of patients return for future treatments and only require one insertion, making the procedure more efficient and comfortable overall.
1 Day post-procedure with 11 pellets using traditional sharp force method. Visible early blood collection around pellet clumps.
1 Week post-procedure with 11 pellets using traditional sharp force method. Visible loculated hematoma preventing pellet absorption and causing severe pain.
1 Week post-procedure with 10 pellets using proprietary Virden method with patented atraumatic trocar. Mild tissue edema, minimal edema and established blood flow to insertion site.